These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 2560555

  • 21. Effect of chronic treatment with the glucocorticoid antagonist RU 486 in man: toxicity, immunological, and hormonal aspects.
    Laue L, Lotze MT, Chrousos GP, Barnes K, Loriaux DL, Fleisher TA.
    J Clin Endocrinol Metab; 1990 Dec; 71(6):1474-80. PubMed ID: 2172280
    [Abstract] [Full Text] [Related]

  • 22. The new steroid analog RU 486 inhibits glucocorticoid action in man.
    Bertagna X, Bertagna C, Luton JP, Husson JM, Girard F.
    J Clin Endocrinol Metab; 1984 Jul; 59(1):25-8. PubMed ID: 6327758
    [Abstract] [Full Text] [Related]

  • 23. Naloxone-induced pituitary-adrenal activation does not differ in patients with depression, obsessive compulsive disorder, and healthy controls.
    Michelson D, Altemus M, Galliven E, Hill L, Greenberg BD, Gold P.
    Neuropsychopharmacology; 1996 Aug; 15(2):207-12. PubMed ID: 8840357
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. The effect of mifepristone (RU 486) on plasma cortisol in Alzheimer's disease.
    Pomara N, Hernando RT, de la Pena CB, Sidtis JJ, Cooper TB, Ferris S.
    Neurochem Res; 2006 May; 31(5):585-8. PubMed ID: 16770728
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Glucocorticoid therapy and pituitary-adrenal responses to corticotropin-releasing hormone.
    Bromberg JS.
    N Engl J Med; 1992 Jul 23; 327(4):283; author reply 283-4. PubMed ID: 1614481
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Long-term therapy of nephrotic syndrome by administration of synthetic ACTH only--with special reference to variation in pituitary-adrenal functions].
    Morimoto Y, Ishijima M, Hashinotsume M, Miyagawa T, Yano S.
    Nihon Rinsho; 1970 Jul 23; 28(7):1931-40. PubMed ID: 4318875
    [No Abstract] [Full Text] [Related]

  • 35. The glucocorticoid receptor and RU 486 in man.
    Bamberger CM, Chrousos GP.
    Ann N Y Acad Sci; 1995 Jun 12; 761():296-310. PubMed ID: 7625728
    [Abstract] [Full Text] [Related]

  • 36. The divergent effect of RU 486 on adrenal function in the dog is related to differences in its pharmacokinetics.
    Spitz IM, Heikinheimo O, Wade CE.
    Acta Endocrinol (Copenh); 1993 May 12; 128(5):459-65. PubMed ID: 8391196
    [Abstract] [Full Text] [Related]

  • 37. Cushing in a Leaf: Endocrine Disruption From a Natural Remedy.
    Martini C, Zanchetta E, Di Ruvo M, Nalesso A, Battocchio M, Gentilin E, Degli Uberti E, Vettor R, Zatelli MC.
    J Clin Endocrinol Metab; 2016 Aug 12; 101(8):3054-60. PubMed ID: 27218272
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Antiglucocorticoid drugs in the treatment of depression.
    Reus VI, Wolkowitz OM.
    Expert Opin Investig Drugs; 2001 Oct 12; 10(10):1789-96. PubMed ID: 11772285
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.